Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators

被引:132
作者
Theocharis, S
Margeli, A
Vielh, P
Kouraklis, G
机构
[1] Univ Athens, Sch Med, Dept Forens Med & Toxicol, GR-11527 Athens, Greece
[2] Inst Curie, Dept Tumor Biol, Unit Cytol & Cytometry, Med Sect, F-75231 Paris 05, France
[3] Aghia Sophia Childrens Hosp, Dept Clin Biochem, GR-11527 Athens, Greece
[4] Univ Athens, Sch Med, Laikon Hosp, Dept Surg, GR-11527 Athens, Greece
关键词
PPAR-gamma ligands; cell cycle; apoptosis; cancer; treatment;
D O I
10.1016/j.ctrv.2004.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for compounds which induce peroxisomal proliferation. PPAR-gamma, the best characterized of the PPARs, is a ligand-activated transcription factor and a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. Recent in vitro and in vivo studies suggest the importance of specific PPAR-gamma ligands as cell-cycle modulators, establishing their antineoplastic properties. In this review, the latest knowledge on the role of PPAR-gamma ligands as cell-cycle modulators is presented, discussing also their role in cell proliferation, apoptosis and cancer. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:545 / 554
页数:10
相关论文
共 88 条
[81]   Modulation of PPARγ activity with pharmaceutical agents:: Treatment of insulin resistance and atherosclerosis [J].
Wang, MH ;
Tafuri, S .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (01) :38-47
[82]   Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid [J].
Westergaard, M ;
Henningsen, J ;
Svendsen, ML ;
Johansen, C ;
Jensen, UB ;
Schroder, HD ;
Kratchmarova, I ;
Berge, RK ;
Iversen, L ;
Bolund, L ;
Kragballe, K ;
Kristiansen, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (05) :702-712
[83]   The PPARs: From orphan receptors to drug discovery [J].
Willson, TM ;
Brown, PJ ;
Sternbach, DD ;
Henke, BR .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (04) :527-550
[84]   Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells [J].
Yang, WL ;
Frucht, H .
CARCINOGENESIS, 2001, 22 (09) :1379-1383
[85]   Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators [J].
Yin, F ;
Wakino, S ;
Liu, ZW ;
Kim, S ;
Hsueh, WA ;
Collins, AR ;
Van Herle, AJ ;
Law, RE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 286 (05) :916-922
[86]   Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ [J].
Zander, T ;
Kraus, JA ;
Grommes, C ;
Schlegel, U ;
Feinstein, D ;
Klockgether, T ;
Landreth, G ;
Koenigsknecht, J ;
Heneka, MT .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (05) :1052-1060
[87]  
Zhu YJ, 1996, GENE EXPRESSION, V6, P185
[88]   Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor [J].
Zhu, YJ ;
Qi, C ;
Jain, S ;
Rao, MS ;
Reddy, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25500-25506